2. Aastrom Biosciences, Inc. (ASTM): Engages in developing autologous cell therapies for the treatment of severe and chronic cardiovascular diseases. Market cap at $59.1M, most recent closing price at $1.35. Of the 6 analysts that have set a target price on the stock, the lowest price target stands at $1.65. This implies a potential upside of 22.22% from current levels around $1.35. Net institutional sales in the current quarter at -2.6M shares, which represents about 5.97% of the company’s float of 43.58M shares.
3. BPZ Resources, Inc. (BPZ): Engages in the exploration, development, and production of oil and natural gas in Peru and Ecuador. Market cap at $367.16M, most recent closing price at $3.14. Of the 6 analysts that have set a target price on the stock, the lowest price target stands at $4. This implies a potential upside of 27.38% from current levels around $3.14. Net institutional sales in the current quarter at -5.3M shares, which represents about 5.93% of the company’s float of 89.39M shares.
4. Callidus Software Inc. (CALD): Provides sales performance management (SPM) software and services. Market cap at $169.73M, most recent closing price at $4.69. Of the 5 analysts that have set a target price on the stock, the lowest price target stands at $6. This implies a potential upside of 27.93% from current levels around $4.69. Net institutional sales in the current quarter at -1.9M shares, which represents about 6.02% of the company’s float of 31.58M shares. 5. MAKO Surgical Corp. (MAKO): A medical device company, markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures in the United States and internationally. Market cap at $512.23M, most recent closing price at $11.15. Of the 8 analysts that have set a target price on the stock, the lowest price target stands at $13. This implies a potential upside of 16.59% from current levels around $11.15. Net institutional sales in the current quarter at -6.1M shares, which represents about 15.13% of the company’s float of 40.31M shares.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
